Tag: acasti pharma

January 14, 2020

Neptune Reveals Acasti Share Sale After Failed Drug Study

Neptune said the months-long sale generated US$4 million in net proceeds, a move geared at monetizing the firm’s non-core investments.
November 26, 2019

Acasti Pharma Updates on TRILOGY 1 Phase 3 Trial

The company announced that the last patient completed their final visit in its TRILOGY 1 pivotal Phase 3 clinical trial...
November 18, 2019

Acasti Pharma Releases Preliminary Data for CaPre in Diabetic Mice

According to the announcement, CaPre demonstrated insulin secretion, which its counterpart metformin is not able to do.
October 13, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Jounce Rises Over 20 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
October 8, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
September 30, 2019

Acasti Pharma Releases Additional Phase 3 Milestones

The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in...
September 9, 2019

Acasti Pharma Receives Funding from the Government of Canada

Acasti Pharma (NASDAQ:ACST, TSXV:ACST) has announced the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) has awarded it...